Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Test‑and‑treat bill sparks sharp debate over pharmacistsscope; committee pauses SB 221
Summary
Supporters urged allowing pharmacists to perform CLIA‑waived tests (strep A, influenza, COVID‑19, RSV) and treat under standing orders; physician groups warned the measure risks fragmenting care and exceeding pharmacists' diagnostic training. Committee held the bill for further drafting.
SB 221 would extend standing‑order authority to allow pharmacists to administer CLIA‑waived tests and treat common acute infections (influenza, COVID‑19, RSV, Group A strep) under Department of Health protocols. Chain and independent pharmacists, pharmacy school faculty and retail groups told the committee that pharmacists are trained to perform…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
